|
| |
| | | 51306 | | 27.08.1991 | | Novartis Pharma Schweiz AG | | 21.12.2005 | | | | | | | | | | | 08.06. | | | | 08.06. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Lamisil 125 mg | Tabletten | Tablets (Terbinafine 125 mg) | D01BA02 | CI | | 02 | Lamisil 250 mg | Tabletten | Tablets (Terbinafine 250 mg) | D01BA02 | CI |
|
|
|